OKUR OnKure Therapeutics, Inc.
Healthcare$4.12-2.14%ClosedMarket Cap: $56.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.31
P/S
0.00
EV/EBITDA
2.30
DCF Value
$4.23
FCF Yield
-88.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-61.0%
ROA
-29.6%
ROIC
-33.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-15.6M | $-15.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-14.1M | $-13.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-63.0M | $-59.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.5M | $-14.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-16.3M | $-15.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-17.0M | $-15.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-33.8M | $-35.2M | $— | — |
| FY null | $0.00 | NaN% | $-54.4M | $-52.7M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-4.7M | $-3.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-14.3M | $-14.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-9.8M | $-9.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $21.1M | $18.5M | $1.39 | — |